ThePrint on MSN4d
Why Indian patients groups are opposing patent requests for blockbuster HIV drug lenacapavir
Granting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to ...
Public health groups raise concern on patent grant to promising, new HIV drug
Patient and public health groups worry about a potential patent grant to Gilead Sciences for the HIV drug lenacapavir in ...
Health activists object to patent filed by US firm Gilead Sciences on anti-HIV drug
The Mumbai-based non-government entity called Sankalp Rehabilitation Trust, which works with HIV-positive people, had opposed ...
Deccan Herald5d
Activists to oppose pharma major’s patent claims on new HIV drug
New Delhi: Indian public health campaigners on Wednesday said they will oppose the patent applications of a promising new but ...
HIV drugs: Indian Patent Office to hear plea against US firm
Sankalp, a civil society organisation working with people vulnerable to HIV, opposed the patent applications in 2021 on ...
Patent opposition case against Gilead’s long-acting HIV injectable drug, comes up this week
The US-based Gilead Sciences’ long-acting injectable HIV drug lenacapavir is at the centre of a patent opposition case ...
BBC1y
Cough-syrup scandal: How did it end up in The Gambia?
"This may result in inconsistent regulatory control over pharmaceutical manufacturing activities," Leena Menghaney, head of Médecins Sans Frontières (MSF) Access Campaign South Asia, says.
AllAfrica.com23d
South Africa: Competition Law Has Again Worked to Fight a Bad Drug Patent, but We Need Other Solutions
Fatima Hassan and Leena Menghaney connect the dots between the two landmark cases and map out what has and has not changed over the last two decades. In the late 1990s and early 2000s, South ...
Pharmabiz5d
Civil Society Organisations oppose Gilead's patent applications for lenacapavir in India
Civil Society Organisations oppose Gilead's patent applications for lenacapavir in India: Our Bureau, New Delhi Tuesday, September 17, 2024, 15:40 Hrs [IST] Civil society organisa ...
News2419d
OPINION | Competition law has again worked to fight a bad drug patent, but we need other solutions
Twenty years ago, a similar case reduced antiretroviral prices, aiding the HIV treatment programme. Fatima Hassan and Leena Menghaney compare these landmark cases and highlight changes over the past ...